T L Lash
Overview
Explore the profile of T L Lash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
535
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang T, Veres K, Farkas D, Lash T, Sorensen H, Gradus J
Osteoporos Int
. 2021 Jul;
32(9):1907.
PMID: 34264356
No abstract available.
2.
Jiang T, Veres K, Kormendine Farkas D, Lash T, Sorensen H, Gradus J
Osteoporos Int
. 2018 Aug;
29(11):2487-2493.
PMID: 30128766
Introduction: We conducted a population-based national cohort study in Denmark to examine the association between PTSD and incident fractures. Methods: We examined the incidence rate of overall and specific fractures...
3.
Svensson E, Farkas D, Gradus J, Lash T, Sorensen H
Eur J Neurol
. 2016 Jan;
23(4):751-6.
PMID: 26756302
Background And Purpose: It has been postulated that stress is part of the etiological process of Parkinson's disease (PD). The risk of PD was examined in a cohort of patients...
4.
Schmidt S, Lash T
Bone Marrow Transplant
. 2015 Mar;
50(6):878-9.
PMID: 25822225
No abstract available.
5.
Lietzen L, Ahern T, Christiansen P, Jensen A, Sorensen H, Lash T, et al.
Ann Oncol
. 2014 Sep;
25(12):2419-2425.
PMID: 25223486
Background: Treatment with synthetic glucocorticoids (GCs) depresses the immune response and may therefore modify cancer outcomes. We investigated the association between GC use and breast cancer recurrence. Materials And Methods:...
6.
Ehrenstein V, Hernandez R, Ulrichsen S, Rungby J, Lash T, Riis A, et al.
BMJ Open
. 2013 Sep;
3(9):e003424.
PMID: 24068766
Objectives: To evaluate the impact of risk minimisation policies on the use of rosiglitazone-containing products and on glycaemic control among patients in Denmark and the UK. Design, Setting And Participants:...
7.
Erichsen R, Horvath-Puho E, Iversen L, Lash T, Sorensen H
Br J Cancer
. 2013 Sep;
109(7):2005-13.
PMID: 24022185
Background: It is unknown whether comorbidity interacts with colorectal cancer (CRC) to increase the rate of mortality beyond that explained by the independent effects of CRC and comorbid conditions. Methods:...
8.
Jensen B, Laustsen S, Petersen A, Soendergaard I, Ernst-Jensen K, Lash T, et al.
Eur J Clin Nutr
. 2013 Jul;
67(9):917-21.
PMID: 23839668
Introduction: Patients diagnosed with (muscle-) invasive bladder cancer (IBC) are more likely to harbour comorbidities due to their advanced age at diagnosis. Under-nutrition is a predictor for postoperative morbidity and...
9.
Cronin-Fenton D, Antonsen S, Cetin K, Daniels A, Borre M, Acquavella J, et al.
Cancer Epidemiol
. 2013 Jul;
37(5):562-8.
PMID: 23830884
Background: Prostate cancer (PC) survivors may have an increased risk of new primary cancers (NPCs) due to shared risk factors or PC-directed treatments. Methods: Using Danish registries, we conducted a...
10.
Grann A, Froslev T, Olesen A, Schmidt H, Lash T
Br J Cancer
. 2013 May;
109(1):265-71.
PMID: 23681188
Background: Comorbid conditions may play an important role in the prognosis of melanoma patients but have received little attention. Methods: Using data from Danish registries, we identified patients diagnosed with...